Home Tags CAT-02-106

Tag: CAT-02-106

TRPH-222 Shows High Response and a Favorable Safety Profile in Non-Hodgkin’s...

Updated results from its Phase 1 multi-center, open-label, monotherapy study of TRPH-222  (formerly called CAT-02-106) in heavily pre-treated patients with relapsed and/or refractory (R/R)...

Interim Results of Phase I Clinical Trial of TRPH-222 in R/R...

The investigational drug TRPH-222 (previously known as CAT-02-106), a next-generation antibody-drug conjugate (ADC), is demonstrating early signs of efficacy in the interim results of...

TRPH-222, a Novel Anti-CD22 ADC, has Significant Anti-Tumor Activity in NHL

A preclinical abstract describing TRPH-222, also known as CAT-02-106, an anti-CD22 antibody-drug conjugate or ADC being developed by Triphase Accelerator for the treatment of...

X